Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4802758 | 6048596 | F | 2 | 4802758-6 | 20040330 | 20051003 | 20051013 | EXP | HQWYE501216APR04 | WYETH PHARMACEUTICALS INC. | 85 | YR | F | N | 64.3 | KG | 20051012 | 20040427 | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4802758 | 1006528830 | PS | MYLOTARG | 1 | INTRAVENOUS | 15.5 MG OVER 2 HOURS, INTRAVENOUS | D | D | 21174 | ||
| 4802758 | 1006542743 | C | VANCOMYCIN | 1 | |||||||
| 4802758 | 1006542744 | C | LEVAQUIN | 1 | |||||||
| 4802758 | 1006542745 | C | DIFLUCAN | 1 | |||||||
| 4802758 | 1006542746 | C | VALTREX | 1 | |||||||
| 4802758 | 1006542747 | C | AMBIEN | 1 | |||||||
| 4802758 | 1006542748 | C | TAMOXIFEN CITRATE | 1 | |||||||
| 4802758 | 1006542749 | C | SENOKOT | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4802758 | 1006528830 | ACUTE MYELOID LEUKAEMIA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4802758 | DE |
| 4802758 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 4802758 | BLOOD UREA INCREASED |
| 4802758 | CELLULITIS |
| 4802758 | DEEP VEIN THROMBOSIS |
| 4802758 | DISEASE PROGRESSION |
| 4802758 | HAEMOGLOBIN DECREASED |
| 4802758 | WHITE BLOOD CELL COUNT DECREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4802758 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4802758 | 1006528830 | 20040326 | 20040326 |